Crosstalk between the lncRNA UCA1 and microRNAs in cancer
- PMID: 31166011
- DOI: 10.1002/1873-3468.13470
Crosstalk between the lncRNA UCA1 and microRNAs in cancer
Abstract
Long non-coding RNAs (lncRNAs) are a major subset of highly conserved non-coding RNAs (ncRNAs) that consist of at least 200 nucleotides and have limited protein-coding potential. Cumulative data have shown that lncRNAs are deregulated in many types of cancer and may control pathophysiological processes of cancer at various levels, including transcription, post-transcription and translation. Recently, lncRNAs have been demonstrated to interact with microRNAs (miRNAs), another major subset of ncRNAs, which regulate physiological and pathological processes by inhibiting target mRNA translation or promoting mRNA degradation. The lncRNA urothelial carcinoma-associated 1 (UCA1) has recently gained much attention as it is overexpressed in many types of cancer and is involved in carcinogenesis. Here, we review the crosstalk between UCA1 and miRNAs during the pathogenesis of cancer, with a focus on cancer-cell proliferation, invasion, drug resistance, and metabolism.
Keywords: UCA1; cancer; drug resistance; invasion; metabolism; micro RNA; proliferation.
© 2019 Federation of European Biochemical Societies.
Similar articles
-
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.Tumour Biol. 2016 Nov;37(11):14733-14743. doi: 10.1007/s13277-016-5348-8. Epub 2016 Sep 15. Tumour Biol. 2016. PMID: 27629141
-
Coexpression of UCA1 and ITGA2 in pancreatic cancer cells target the expression of miR-107 through focal adhesion pathway.J Cell Physiol. 2019 Aug;234(8):12884-12896. doi: 10.1002/jcp.27953. Epub 2018 Dec 19. J Cell Physiol. 2019. PMID: 30569514
-
The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.Oncotarget. 2017 Feb 14;8(7):12472-12483. doi: 10.18632/oncotarget.13957. Oncotarget. 2017. PMID: 27992370 Free PMC article. Review.
-
Long non-coding RNA UCA1 regulates the proliferation, migration and invasion of human lung cancer cells by modulating the expression of microRNA-143.Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8343-8352. doi: 10.26355/eurrev_201812_16532. Eur Rev Med Pharmacol Sci. 2018. PMID: 30556875
-
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?Cancer Lett. 2021 Jul 1;509:63-80. doi: 10.1016/j.canlet.2021.03.025. Epub 2021 Apr 7. Cancer Lett. 2021. PMID: 33838282 Review.
Cited by
-
The role of long noncoding RNAs in therapeutic resistance in cervical cancer.Front Cell Dev Biol. 2022 Nov 9;10:1060909. doi: 10.3389/fcell.2022.1060909. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36438563 Free PMC article. Review.
-
Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA.Mol Cancer. 2020 Jan 29;19(1):18. doi: 10.1186/s12943-020-1132-x. Mol Cancer. 2020. PMID: 31996265 Free PMC article.
-
The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulation.Cell Death Dis. 2023 May 24;14(5):341. doi: 10.1038/s41419-023-05862-5. Cell Death Dis. 2023. PMID: 37225681 Free PMC article.
-
LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway.Oxid Med Cell Longev. 2022 Jun 28;2022:5215748. doi: 10.1155/2022/5215748. eCollection 2022. Oxid Med Cell Longev. 2022. Retraction in: Oxid Med Cell Longev. 2023 Dec 29;2023:9864513. doi: 10.1155/2023/9864513. PMID: 35799892 Free PMC article. Retracted.
-
What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1).Noncoding RNA Res. 2021 Dec 1;6(4):174-186. doi: 10.1016/j.ncrna.2021.11.001. eCollection 2021 Dec. Noncoding RNA Res. 2021. PMID: 34938928 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
